Stratification of clear cell renal cell carcinoma by signaling pathway analysis

被引:7
|
作者
Cremona, Mattia [1 ]
Espina, Virginia [2 ]
Caccia, Dario [1 ]
Veneroni, Silvia [1 ]
Colecchia, Maurizio [3 ]
Pierobon, Mariaelena [2 ]
Deng, Jianghong [2 ]
Mueller, Claudius [2 ]
Procopio, Giuseppe [4 ]
Lanzi, Cinzia [1 ]
Daidone, Maria Grazia [1 ]
Cho, William C. S. [5 ]
Petricoin, Emanuel F. [2 ]
Liotta, Lance [2 ]
Bongarzone, Italia [1 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy
[2] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA
[3] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy
[5] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
关键词
autophagy; HIF; hypoxia; mTOR; renal cell carcinoma; reverse-phase protein array; signaling pathway; GROWTH-FACTOR RECEPTOR; TARGETED THERAPY; CANCER; AUTOPHAGY; MTOR; EGFR; VHL; PHOSPHORYLATION; MICRODISSECTION; INACTIVATION;
D O I
10.1586/14789450.2014.893193
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Investigation of cell signaling pathways in 16 clear cell renal cell carcinomas to identify groups based on commonly shared phosphorylation-driven signaling networks. Using laser capture microdissection and reverse-phase protein arrays, we profiled 75 key nodes spanning signaling pathways important in tumorigenesis. Analysis revealed significantly different (P < 0.05) signaling levels for 27 nodes between two groups of samples, designated A (4 samples; high EGFR, RET, and RASGFR1 levels, converging to activate AKT/mTOR) and B (12 samples; high ERK1/2 and STAT phosphorylation). Group B was further partitioned into groups C (7 samples; elevated expression of LC3B) and D (5 samples; activation of Src and STAT). Network analysis indicated that group A was characterized by signaling pathways related to cell cycle and proliferation, and group B by pathways related to cell death and survival. Homogeneous clear cell renal cell carcinomas could be stratified into at least two major functional groups.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 50 条
  • [1] Activation of the mTOR signaling pathway in renal clear cell carcinoma
    Robb, Victoria A.
    Karbowniczek, Magdalena
    Klein-Szanto, Andres. J.
    Henskex, Elizabeth P.
    JOURNAL OF UROLOGY, 2007, 177 (01) : 346 - 352
  • [2] VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma
    Linehan, W. Marston
    Rubin, Jeffrey S.
    Bottaro, Donald P.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (04) : 753 - 756
  • [3] Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma
    Pezzicoli, Gaetano
    Ciciriello, Federica
    Musci, Vittoria
    Salonne, Francesco
    Ragno, Anna
    Rizzo, Mimma
    CURRENT ONCOLOGY, 2023, 30 (10) : 9276 - 9290
  • [4] Features of increased malignancy in eosinophilic clear cell renal cell carcinoma
    Nilsson, Helen
    Lindgren, David
    Axelson, Hakan
    Brueffer, Christian
    Saal, Lao H.
    Lundgren, Jaana
    Johansson, Martin E.
    JOURNAL OF PATHOLOGY, 2020, 252 (04) : 384 - 397
  • [5] Exploiting the circuit breaker cancer evolution model in human clear cell renal cell carcinoma
    Hsieh, James J.
    Cheng, Emily H.
    CELL STRESS, 2020, 4 (08) : 191 - 198
  • [6] mTOR pathway inhibition in renal cell carcinoma
    Pinto Marin, Alvaro
    Redondo Sanchez, Andres
    Espinosa Arranz, Enrique
    Zamora Aunon, Pilar
    Castelo Fernandez, Beatriz
    Gonzalez Baron, Manuel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (04) : 356 - 361
  • [7] DUSP9 Suppresses Proliferation and Migration of Clear Cell Renal Cell Carcinoma via the mTOR Pathway
    Luo, Jing
    Luo, Xing
    Liu, Xin
    Fang, Zhenqiang
    Xu, Jie
    Li, Longkun
    ONCOTARGETS AND THERAPY, 2020, 13 : 1321 - 1330
  • [8] CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
    Wang, Qi
    Xu, Jiaju
    Xiong, Zhiyong
    Xu, Tianbo
    Liu, Jingchong
    Liu, Yuenan
    Chen, Jiaping
    Shi, Jian
    Shou, Yi
    Yue, Changjie
    Liu, Di
    Liang, Huageng
    Yang, Hongmei
    Yang, Xiong
    Zhang, Xiaoping
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [9] mTOR pathway in renal cell carcinoma
    Hanna, Sara C.
    Heathcote, Samuel A.
    Kim, William Y.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (02) : 283 - 292
  • [10] Evolution of the HIF targeted therapy in clear cell renal cell carcinoma
    Golijanin, Borivoj
    Malshy, Kamil
    Khaleel, Sari
    Lagos, Galina
    Amin, Ali
    Cheng, Liang
    Golijanin, Dragan
    Mega, Anthony
    CANCER TREATMENT REVIEWS, 2023, 121